我国医药制造业产业集聚对创新能力的影响机制研究

The Impact of Pharmaceutical Industrial Agglomeration on Its Innovation Ability in China

摘要: 医药制造业是我国高技术产业六大产业之一，其创新能力的提升对我国整体创新能力和综合国力的提升具有重要意义。在经济发展的不同阶段，医药制造业产业集聚特征对我国医药制造业创新能力的影响机制呈现出不同的特点。本文立足于分析我国现阶段医药制造业的发展特征，运用2010~2016年我国25个省及直辖市的完整数据，探讨了现阶段我国医药制造业专业化集聚水平、多样化集聚水平、产业竞争强度、创新劳动力投入和创新资本投入对该产业创新能力的影响。最后，根据相关数据分析结果，本文提出了提升我国地区医药制造业创新绩效的相关决策建议。

Abstract: Pharmaceutical industry is one of the six important high-tech industries in China. Improving its innovation ability is the key to enhance innovation ability and core competence of China. In the developing of pharmaceutical industry, the mechanism of the impact of pharmaceutical industrial agglomeration on its innovation ability is changing. This paper analyses the developing charactistics of Chinese pharmaceutical industry. By collecting and analyzing the complete data of 25 provinces and municipalities from 2010 to 2016, the impact of pharmaceutical industrial agglomeration status, competitive intensity, innovative labor and capital for innovation on innovation ability is discussed in this paper. Based on data analysis result, some strategies for improving Chinese pharmaceutical industry’s innovation ability are proposed.